Beijing Yongyu Investment Management Co., Ltd. signed a stake transfer agreement to acquire additional 12.8% in Baolingbao Biology Co.,Ltd. (SZSE:002286) from Liu Zongli, Xue Jianping, Yang Yuanzhi and Wang Naiqian for approximately CNY 940 million on February 6, 2018. As per terms, Beijing Yongyu Investment Management Co., Ltd. will acquire 47.2 million shares for CNY 19.92 per share. The consideration will be funded using own funds. On July 10, 2020, Beijing Yongyu Investment Management Co., Ltd. signed a supplementary share transfer agreement with Liu Zongli. Liu Zong Li and Yongyu for acquiring 24.93 million shares of Baolingbao Biology representing 6.75% stake for CNY 205 million. Beijing Yongyu Investment Management agreed to pay CNY 4.2 million to Liu Zongli before January 5, 2021, and CNY 40 million to Liu Zongli before January 15, 2021, and the remaining amount to be paid by February 28, 2021. The transaction expected close on December 31, 2020. As of January 4, 2021, the transaction expected to close on February 28, 2021. Beijing Yongyu Investment Management Co., Ltd. cancelled the acquisition of additional 6.8% in Baolingbao Biology Co.,Ltd. (SZSE:002286) from Liu Zongli, Xue Jianping, Yang Yuanzhi and Wang Naiqian on January 28, 2021. The buyers will not be able to fulfill the payment requirements.